Pharmaceuticals, Biotechnology and Life Sciences
NDA is supported by data from the phase 3 ASCERTAIN study of oral C-DEC in adults with intermediate- and high-risk…
— Net income of $1.2 million driven by 6.7% revenue growth from prior year period and 18.3% operating margin —…
Transaction Expected to be Immediately Accretive to Revenues and Adjusted EPS Slides to accompany this announcement are posted to Ligand.com…
SALT LAKE CITY–(BUSINESS WIRE)–PolarityTE, Inc. (Nasdaq: PTE), a biotechnology company developing and commercializing regenerative tissue products and biomaterials, today announced…
CRESSKILL, N.J.–(BUSINESS WIRE)–Vascular Therapies, a clinical-stage biopharma company focused on improving vascular access outcomes in patients with kidney disease, today…
PRINCETON, N.J. & MENLO PARK, Calif.–(BUSINESS WIRE)–#immunotherapy–Advaxis, Inc. (Nasdaq: ADXS), a clinical-stage biotechnology company focused on the development and commercialization…
NORTHBROOK, Ill.–(BUSINESS WIRE)–Continuum Clinical, a global clinical trial enrollment company, is proud to announce Paul Ivsin as the new vice…
LONDON–(BUSINESS WIRE)–#CompetitiveIntelligence–Infiniti Research, a leading market intelligence solutions provider, has recently announced the completion of its latest success story on…
Signatera test used for patient selection and monitoring to accelerate molecular proof of concept CAMBRIDGE, Mass. & SAN CARLOS, Calif.–(BUSINESS…
WOONSOCKET, R.I. & TORONTO–(BUSINESS WIRE)–$ABAHF #AbacusHealthProducts–Abacus Health Products, Inc. (CSE: ABCS, OTCQX:ABAHF) (“Abacus” or the “Company”) is pleased to announce…